(Q43857789)

English

Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). (English)

1 reference

Europe PubMed Central

27 November 2017

type-1 diabetes

1 reference

based on heuristic

inferred from title

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Shigehiro Katayama

1

1 reference

Europe PubMed Central

27 November 2017

Ryuichi Kikkawa

2

1 reference

Europe PubMed Central

27 November 2017

Syo Isogai

3

1 reference

Europe PubMed Central

27 November 2017

Nozomu Sasaki

4

1 reference

Europe PubMed Central

27 November 2017

Nobuo Matsuura

5

1 reference

Europe PubMed Central

27 November 2017

Naoko Tajima

6

1 reference

Europe PubMed Central

27 November 2017

Tatsuhiko Urakami

7

1 reference

Europe PubMed Central

27 November 2017

Yasuko Uchigata

8

1 reference

Europe PubMed Central

27 November 2017

Yasuo Ohashi

9

1 reference

Europe PubMed Central

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2002

1 reference

Europe PubMed Central

27 November 2017

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

27 November 2017

55

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

113-121

1 reference

Europe PubMed Central

27 November 2017

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal protective effect of enalapril in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900289-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8227(01)00289-3

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43857789&oldid=2103939973"